Endorsements
Rep. Glenn Grothman (WI-6)
Glenn Grothman is a U.S. Representative for Wisconsin’s 6th Congressional District, proudly serving in Congress since 2015. Throughout his career, Rep. Grothman has championed policies that empower workers, protect seniors, reform welfare systems, and support economic growth for families and communities across Wisconsin and the nation.
Why We Endorse
Championing Longevity Science
Rep. Glenn Grothman has represented Wisconsin’s 6th Congressional District in the U.S. House of Representatives since 2015. He serves on several key committees, including the Committee on Education and the Workforce, the Committee on Oversight and Accountability, the Committee on the Judiciary, and the Committee on the Budget.
Representing a district with a strong manufacturing and workforce base, Rep. Grothman has focused on policies that support innovation, workforce development, and long-term economic sustainability. His work on education, labor, and fiscal policy intersects with efforts to strengthen the biomedical research ecosystem and ensure that scientific and technological advances translate into real-world benefits for American workers and families.
Rep. Grothman has consistently emphasized oversight, responsible stewardship of federal resources, and policies aimed at improving long-term outcomes in health, productivity, and economic security — priorities that align with A4LI’s mission to advance research, innovation, and policy solutions that extend healthy lifespan and reduce the burden of age-related disease.
Prior to Congress, Rep. Grothman served in the Wisconsin State Assembly and State Senate. He is a graduate of the University of Wisconsin–Madison, where he earned both his undergraduate degree and Juris Doctor.
Want to be Involved?
Are You a Candidate Interested in Endorsement?
A4LI welcomes discussions with public servants who are committed to:
📌 Expanding healthy human lifespan through science-based policy
📌 Supporting regulatory innovation for next-generation therapies
📌 Engaging with stakeholders in research, biotech, and patient advocacy
